Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: Which is better in patients with radically resected extrahepatic biliary tract cancer?: A non-randomized, single center study

BMC Cancer

Volumn 9, Issue , 2009, Pages 345-

  Lim, Kyu Hyoung ^a   Oh, Do Youn ^a   Chie, Eui K ^a   Jang, Jin Young ^a   Im, Seock Ah ^a   Kim, Tae You ^a   Kim, Sun Whe ^a   Ha, Sung W ^a   Bang, Yung Jue ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ANTINEOPLASTIC AGENT; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; TS 1; UFT; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; BILIARY TRACT SURGERY; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; DISEASE FREE SURVIVAL; FEMALE; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; OVERALL SURVIVAL; SINGLE DRUG DOSE; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME;

EID: 70449358700     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-345     Document Type: Article

References (30)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005, 55:10-30. 10.3322/canjclin.55.1.10, 15661684.
2. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL. Cholangiocarcinoma: A spectrum of intrahepatic, perihilar and distal tumors. Ann Surg 1996, 224:463-473. 10.1097/00000658-199610000-00005, 1235406, 8857851.
3. D'Angelica MI, Jarnagin WR, Blumgart LH. Resectable hilar cholangiocarcinoma: surgical treatment and long-term outcome. Surg Today 2004, 34:885-890. 10.1007/s00595-004-2832-3, 15526120.
4. Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 2005, 103:1210-1216. 10.1002/cncr.20906, 15685618.
5. Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, Wagman R, Blumgart LH, Fong Y. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 2003, 98:1689-1700. 10.1002/cncr.11699, 14534886.
6. Kopelson G, Galdabini J, Warshaw AL, Gunderson LL. Patterns of failure after curative surgery for extra-hepatic biliary tract carcinoma: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1981, 7:413-417.
7. González González D, Gouma DJ, Rauws EA, van Gulik TM, Bosma A, Koedooder C. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. Ann Oncol 1999, 10:215-220. 10.1023/A:1008339709327, 10436826.
8. Gerhards MF, van Gulik TM, González González D, Rauws EA, Gouma DJ. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 2003, 27:173-179.
9. Kamada T, Saitou H, Takamura A, Nojima T, Okushiba SI. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys 1996, 34:767-774.
10. Kim S, Kim SW, Bang YJ, Heo DS, Ha SW. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 2002, 54:414-419.
11. Serafini FM, Sachs D, Bloomston M, Carey LC, Karl RC, Murr MM, Rosemurgy AS. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy. Am Surg 2001, 67:839-844.
12. Todoroki T, Ohara K, Kawamoto T, Koike N, Yoshida S, Kashiwagi H, Otsuka M, Fukao K. Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys 2000, 46:581-587.
13. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 2002, 95:1685-1695. 10.1002/cncr.10831, 12365016.
14. Glimelius B, Hoffman K, Sjödén PO, Jacobsson G, Sellström H, Enander LK, Linné T, Svensson C. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996, 7:593-600.
15. Frederick LG, David LP, Irvin DF, April GF, Charles MB, Daniel GH, Monica M. American Joint Committee on Cancer. AJCC cancer staging manual 2002, New York: Springer-Verlag, 6.
16. Chitwood WR, Meyers WC, Heaston DK, Herskovic AM, McLeod ME, Jones RS. Diagnosis and treatment of primary extrahepatic bile duct tumor. Am J Surg 1982, 143:99-106. 10.1016/0002-9610(82)90137-4, 7053662.
17. Cameron JL, Pitt HA, Zinner MJ, Kaufman SL, Coleman J. Management of proximal cholangiocarcinoma by surgical resection and radiotherapy. Am J Surg 1990, 159:91-97. 10.1016/S0002-9610(05)80612-9, 1688486.
18. Kraybill WG, Lee H, Picus J, Ramachandran G, Lopez MJ, Kucik N, Myerson RJ. Multidisciplinary treatment of biliary tract cancers. J Surg Oncol 1994, 55:239-245. 10.1002/jso.2930550408, 8159005.
19. Langer JC, Langer B, Taylor BR, Zeldin R, Cummings B. Carcinoma of the extrahepatic bile ducts: Results of an aggressive surgical approach. Surgery 1985, 98:752-759.
20. Rossi RL, Heiss FW, Beckmann CF, Braasch JW. Management of cancer of the bile duct. Surg Clin North Am 1985, 65:59-78.
21. Yeo C, Pitt H, Cameron J. Cholangiocarcinoma. Surg Clin North Am 1990, 70:1429-1447.
22. Schoenthaler R, Phillips TL, Castro J, Efird JT, Better A, Way LW. Carcinoma of the extrahepatic bile ducts: The University of California at San Francisco experience. Ann Surg 1994, 219:267-274. 10.1097/00000658-199403000-00006, 1243134, 8147607.
23. Oh D, Lim do H, Heo JS, Choi SH, Choi DW, Ahn YC, Park W, Huh SJ. The role of adjuvant radiotherapy in microscopic tumor control after extrahepatic bile duct cancer surgery. Am J Clin Oncol 2007, 30:21-25. 10.1097/01.coc.0000245467.97180.78, 17278890.
24. Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CJ, Lillemore KD, Cameron JL. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg 1995, 221:788-797. 10.1097/00000658-199506000-00017, 1234714, 7794082.
25. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999, 230:776-782. 10.1097/00000658-199912000-00006, 1420941, 10615932.
26. Kresl JJ, Schild SE, Henning GT, Gunderson LL, Donohue J, Pitot H, Haddock MG, Nagorney D. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 2002, 52:167-175.
27. Mahe M, Romestaing P, Talon B, Ardiet JM, Salerno N, Sentenac I, Gerard JP. Radiation therapy in extrahepatic bile duct carcinoma. Radiother Oncol 1991, 21:121-127. 10.1016/0167-8140(91)90084-T, 1866463.
28. Falkson G, MacIntyre JM, Moertel CG. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 1984, 54:965-969. 10.1002/1097-0142(19840915)54:6<965::AID-CNCR2820540603>3.0.CO;2-X, 6235908.
29. Kim TW, Chang HM, Kang HJ, Lee JR, Ryu MH, Ahn JH, Kim JH, Lee JS, Kang YK. Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer. Ann Oncol 2003, 14:1115-1120. 10.1093/annonc/mdg281, 12853355.
30. Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C. Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer 2004, 91:1769-1774. 10.1038/sj.bjc.6602208, 2410053, 15505626.